129 related articles for article (PubMed ID: 8697444)
1. Lack of tumor promoting effects of KCB-1, a recombinant human basic fibroblast growth factor, on two-stage skin carcinogenesis in female CD-1 (ICR) mice.
Tanaka H; Takesada Y; Shibata MA; Kawabe M; Sano M; Tamano S; Sugimoto H; Nakamura T; Hagiwara A
Cancer Lett; 1996 Aug; 105(2):195-202. PubMed ID: 8697444
[TBL] [Abstract][Full Text] [Related]
2. Effects of dose and duration of treatment with the tumor-promoting agent, 12-O-tetradecanoylphorbol-13-acetate on mouse skin carcinogenesis.
Verma AK; Boutwell RK
Carcinogenesis; 1980 Mar; 1(3):271-6. PubMed ID: 22283009
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the co-promoting activity of gamma interferon in SENCAR and C57BL/6 mouse skin by difluoromethylornithine and the scheduling and duration of interferon treatment.
Reiners JJ; Pavone A; Rupp T; Cantu AR
Carcinogenesis; 1990 Jan; 11(1):129-37. PubMed ID: 2104781
[TBL] [Abstract][Full Text] [Related]
4. Evidence that mirex promotes a unique population of epidermal cells that cannot be distinguished by their mutant Ha-ras genotype.
Kim TW; Porter KL; Foley JF; Maronpot RR; Smart RC
Mol Carcinog; 1997 Sep; 20(1):115-24. PubMed ID: 9328442
[TBL] [Abstract][Full Text] [Related]
5. Acceleration of papilloma growth in mice fed high-fat diets during promotion of two-stage skin carcinogenesis.
Birt DF; Pelling JC; Tibbels MG; Schweickert L
Nutr Cancer; 1989; 12(2):161-8. PubMed ID: 2496398
[TBL] [Abstract][Full Text] [Related]
6. Vitamin E is a complete tumor promoter in mouse skin.
Mitchel RE; McCann R
Carcinogenesis; 1993 Apr; 14(4):659-62. PubMed ID: 8472330
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of 129/SvEv mice in two-stage carcinogenesis protocols to 12-O-tetradecanoylphorbol-13-acetate promotion.
Reiners JJ; Singh KP
Carcinogenesis; 1997 Mar; 18(3):593-7. PubMed ID: 9067561
[TBL] [Abstract][Full Text] [Related]
8. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin.
Hennings H; Glick AB; Lowry DT; Krsmanovic LS; Sly LM; Yuspa SH
Carcinogenesis; 1993 Nov; 14(11):2353-8. PubMed ID: 8242866
[TBL] [Abstract][Full Text] [Related]
9. Hyperthermia and phorbol ester tumor promotion in mouse skin.
Mitchel RE; Morrison DP; Gragtmans NJ; Jevcak JJ
Carcinogenesis; 1986 Sep; 7(9):1505-10. PubMed ID: 3091284
[TBL] [Abstract][Full Text] [Related]
10. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
[TBL] [Abstract][Full Text] [Related]
11. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.
Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A
Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134
[TBL] [Abstract][Full Text] [Related]
12. NTP Initiation/Promotion Study of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in Swiss (CD-1(R)) Mice (Mouse Skin Study).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1995 May; 444():1-136. PubMed ID: 12595919
[TBL] [Abstract][Full Text] [Related]
13. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
Owens DM; Spalding JW; Tennant RW; Smart RC
Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of dietary beta-carotene on papilloma and carcinoma formation induced by an initiation-promotion protocol in SENCAR mouse skin.
Chen LC; Sly L; Jones CS; Tarone R; De Luca LM
Carcinogenesis; 1993 Apr; 14(4):713-7. PubMed ID: 8472337
[TBL] [Abstract][Full Text] [Related]
15. Enhanced skin carcinogenesis in transgenic mice with high expression of glutathione peroxidase or both glutathione peroxidase and superoxide dismutase.
Lu YP; Lou YR; Yen P; Newmark HL; Mirochnitchenko OI; Inouye M; Huang MT
Cancer Res; 1997 Apr; 57(8):1468-74. PubMed ID: 9108447
[TBL] [Abstract][Full Text] [Related]
16. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols.
Iversen OH
APMIS Suppl; 1994; 41():1-38. PubMed ID: 7946481
[TBL] [Abstract][Full Text] [Related]
17. 12-O-tetradecanoylphorbol-13-acetate-mediated systemic co-promotion in the murine skin multistage carcinogenesis protocol.
Reiners JJ; Pavone A; Maldve R; Fischer SM
Carcinogenesis; 1993 Mar; 14(3):411-5. PubMed ID: 8453717
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz[a]anthracene.
Scribner JD; Scribner NK; McKnight B; Mottet NK
Cancer Res; 1983 May; 43(5):2034-41. PubMed ID: 6403231
[TBL] [Abstract][Full Text] [Related]
19. S/RV Cri-ba, a hairless mouse strain sensitive to skin tumorigenesis by suboptimal doses of 7,12-dimethylbenz[a]anthracene, initiation-promotion and two stage promotion protocols.
Bhisey RA; Veturkar PL
Cancer Lett; 1990 Jun; 52(1):63-9. PubMed ID: 2112980
[TBL] [Abstract][Full Text] [Related]
20. Lack of promotion of 7,12-dimethylbenz[a]anthracene-initiated mouse skin carcinogenesis by 1.5 GHz electromagnetic near fields.
Imaida K; Kuzutani K; Wang J; Fujiwara O; Ogiso T; Kato K; Shirai T
Carcinogenesis; 2001 Nov; 22(11):1837-41. PubMed ID: 11698347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
